JEFF RICKERT: Open Payments
NPI 1972719151 · ROCKWALL, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,564 in 85 payments from 21 companies in 2025. Trend: 2023 $1,149 · 2024 $1,424 · 2025 $1,564
Food & beverage: $1,564
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 11 | $209 |
| Corium, LLC | 7 | $183 |
| Amgen Inc. | 13 | $165 |
| Novo Nordisk Inc | 7 | $162 |
| Abbott Laboratories | 7 | $149 |
| Astellas Pharma US Inc | 11 | $148 |
| Corcept Therapeutics | 2 | $69 |
| Lilly USA, LLC | 4 | $65 |
| Axsome Therapeutics, Inc. | 3 | $62 |
| Sumitomo Pharma America, Inc. | 3 | $56 |
Products named: Azstarys, FREESTYLE LIBRE 3, Veozah, EVENITY, Ozempic, ELIQUIS, Korlym, MOUNJARO.
Industry payments across TX — which companies pay providers there.
